A questionnaire was given to patients following eye removal to assess the rate of phantom eye pain (PEP) and patient health-related quality of life (QoL). Source: AAO
A secondary analysis of data from 2 Postnatal Growth and ROP (G-ROP) studies compared anti-VEGF treatment with laser therapy for short-term prevention of retinal detachment in type 1 retinopathy of prematurity (ROP). Source: AAO
A secondary analysis of data from the LAMP study assessed factors affecting response to 3 different concentrations of atropine in terms of change in spherical equivalent and elongation of axial length during a 2-year period. Source: AAO
Using clinical examination images, investigators reviewed and evaluated the feasibility and reproducibility of a quantitative vascular severity scale for assessing retinopathy of prematurity (ROP) cases. Source: AAO
A study was conducted to determine which factors influence patients to complete patient-reported outcome (PRO) measure questionnaires following laser vision correction surgery. Source: AAO
A laboratory-based study compared modular transfer function (MTF) in IOLs with 1 of 2 distinct IOL opacification patterns vs. IOL controls. Source: AAO
Patients who underwent orbitotomy for primary intraconal tumors were evaluated for the rate of postoperative severe vision impairment (PSVI) and the most common risk factors for impairment. Source: AAO
Using a patient population from the randomized FAST clinical trial which studied the efficacy and safety of antimetabolites for noninfectious uveitis, investigators assessed whether these agents had an effect on patient quality of life (QoL). Source: AAO
A once-daily dose of the novel drug omidenepag isopropyl showed the same efficacy as twice-daily dosing and was more tolerable for patients. Source: AAO
Investigators evaluated the rate of SARS-CoV-2 in tears collected from patients with COVID-19 in intensive care units in Italy and the rate in healthy participants. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
